BR112022014114A2 - Composições para gerenciar doença pulmonar obstrutiva crônica - Google Patents
Composições para gerenciar doença pulmonar obstrutiva crônicaInfo
- Publication number
- BR112022014114A2 BR112022014114A2 BR112022014114A BR112022014114A BR112022014114A2 BR 112022014114 A2 BR112022014114 A2 BR 112022014114A2 BR 112022014114 A BR112022014114 A BR 112022014114A BR 112022014114 A BR112022014114 A BR 112022014114A BR 112022014114 A2 BR112022014114 A2 BR 112022014114A2
- Authority
- BR
- Brazil
- Prior art keywords
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- compositions
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062962343P | 2020-01-17 | 2020-01-17 | |
| US202063126920P | 2020-12-17 | 2020-12-17 | |
| PCT/US2021/013763 WO2021146648A1 (en) | 2020-01-17 | 2021-01-16 | Compositions for managing chronic obstructive pulmonary disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022014114A2 true BR112022014114A2 (pt) | 2022-09-13 |
Family
ID=76856592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022014114A BR112022014114A2 (pt) | 2020-01-17 | 2021-01-16 | Composições para gerenciar doença pulmonar obstrutiva crônica |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11925606B2 (enExample) |
| EP (1) | EP4090340B1 (enExample) |
| JP (1) | JP7746272B2 (enExample) |
| KR (1) | KR20220128382A (enExample) |
| CN (1) | CN115175672B (enExample) |
| AU (1) | AU2021207536B2 (enExample) |
| BR (1) | BR112022014114A2 (enExample) |
| CA (1) | CA3164013A1 (enExample) |
| WO (1) | WO2021146648A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023554642A (ja) * | 2020-12-17 | 2023-12-28 | サミ－サビンサ グループ リミテッド | ビスデメトキシクルクミン組成物の抗肥満能 |
| WO2022203721A1 (en) * | 2021-03-25 | 2022-09-29 | Muhammed Majeed | Compositions and methods for inhibiting proteolytic activation of viruses |
| RS20220433A1 (sr) | 2022-05-11 | 2023-11-30 | Milan Prokin | Višeciljni antivirusni dodatak ishrani |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040266883A1 (en) * | 1999-10-27 | 2004-12-30 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| US20100179103A1 (en) * | 2008-07-21 | 2010-07-15 | Ketan Desai | Curcumin cyclodextrin combination for preventing or treating various diseases |
| US8486909B2 (en) * | 2009-06-24 | 2013-07-16 | Board Of Regents Of The University Of Nebraska | Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease |
| EP2475380A1 (en) * | 2009-09-11 | 2012-07-18 | Protaffin Biotechnologie AG | Composition for treatment of cxcl8-mediated lung inflammation |
| WO2012047674A2 (en) * | 2010-09-27 | 2012-04-12 | Microdose Therapeutx, Inc. | Methods and compositions for disease treatment using inhalation |
| ITMI20132169A1 (it) * | 2013-12-20 | 2015-06-21 | Thompson S R L | Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata |
| JP2017516764A (ja) * | 2014-04-18 | 2017-06-22 | オムニアクティブ ヘルス テクノロジーズ リミテッド | クルクミン組成物及びその使用 |
| WO2016145159A1 (en) * | 2015-03-10 | 2016-09-15 | The Research Foundation For The State University Of New York | Chemically modified curcumins for use in the production of lipoxins |
| JP6688009B2 (ja) * | 2015-04-15 | 2020-04-28 | 長谷川 浩二 | 酸化変性ｌｄｌ複合体抑制剤 |
| CN105998043B (zh) * | 2016-07-01 | 2018-11-27 | 吉林大学 | 槐属双苷在制备防治慢性阻塞性肺疾病药物中的应用 |
-
2021
- 2021-01-16 WO PCT/US2021/013763 patent/WO2021146648A1/en not_active Ceased
- 2021-01-16 US US17/151,121 patent/US11925606B2/en active Active
- 2021-01-16 BR BR112022014114A patent/BR112022014114A2/pt unknown
- 2021-01-16 JP JP2022543653A patent/JP7746272B2/ja active Active
- 2021-01-16 AU AU2021207536A patent/AU2021207536B2/en active Active
- 2021-01-16 EP EP21741037.2A patent/EP4090340B1/en active Active
- 2021-01-16 KR KR1020227027330A patent/KR20220128382A/ko active Pending
- 2021-01-16 CA CA3164013A patent/CA3164013A1/en active Pending
- 2021-01-16 CN CN202180015345.2A patent/CN115175672B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11925606B2 (en) | 2024-03-12 |
| CN115175672A (zh) | 2022-10-11 |
| AU2021207536B2 (en) | 2025-04-10 |
| CA3164013A1 (en) | 2021-07-22 |
| NZ790708A (en) | 2025-05-02 |
| CN115175672B (zh) | 2024-07-02 |
| WO2021146648A1 (en) | 2021-07-22 |
| JP2023512489A (ja) | 2023-03-27 |
| AU2021207536A1 (en) | 2022-08-11 |
| KR20220128382A (ko) | 2022-09-20 |
| US20210220290A1 (en) | 2021-07-22 |
| EP4090340A1 (en) | 2022-11-23 |
| EP4090340B1 (en) | 2026-05-06 |
| EP4090340A4 (en) | 2024-02-21 |
| JP7746272B2 (ja) | 2025-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR042578A1 (es) | Inhibidores de la sintesis de mucina | |
| MX2018000688A (es) | Triciclicos sustituidos y metodo para usarlos. | |
| HRP20130052T1 (hr) | Lijeäśenje respiratorne bolesti | |
| UA106098C2 (uk) | Аерозольна композиція для хозл | |
| WO2020217116A3 (en) | Long acting inhalation compositions of indacaterol | |
| JP2017527618A5 (enExample) | ||
| JP2023512489A5 (enExample) | ||
| CL2020000597A1 (es) | Métodos y composiciones para tratar enfermedades pulmonares crónicas. | |
| BR112022020403A2 (pt) | Composições e métodos para tratar complicações de infecções virais e outros transtornos repiratórios | |
| WO2024086777A3 (en) | Compounds and methods for treating diseases caused by viruses and bacteria | |
| ECSP24002381A (es) | Proteínas actrii y usos de las mismas | |
| CO2022005269A2 (es) | Composición de polvo seco inhalable contra enfermedades pulmonares | |
| Thompson | Neuroendocrine tumors of the larynx | |
| MX2024001207A (es) | Composiciones y metodos para el tratamiento de displasia broncopulmonar (bpd) y la hipertension pulmonar asociada a bpd. | |
| JP2023502259A5 (enExample) | ||
| JP2023520770A5 (enExample) | ||
| Liu et al. | Endobronchial solitary fibrous tumor: imaging and bronchoscopic findings | |
| NO20006665D0 (no) | Substituert ß-diketoner og deres anvendelse | |
| Mitre et al. | Correction to: Anesthesia for Intense Pulsed Light (IPL) Treatments | |
| Muhammed et al. | Assessment of pulmonary artery pressure in chronic obstructive pulmonary disease patients without resting hypoxemia | |
| WO2022221602A3 (en) | Compositions and methods for treating and/or preventing lung injury | |
| Kim | Importance of alveolar recruitment strategy revisited | |
| Dhavalshankh et al. | 2023e-17-nail _dystrophy_Heller | |
| Van Eeden et al. | D37 HELP: ADVANCES IN COPD THERAPEUTICS: Effect Of Statins On The Retention Of Ambient Particulate Matters (pm) In COPD | |
| Saha et al. | You Have Mucous Membrane Pemphigoid, Causing Subglottic Stenosis, and You Lived to Tell About It? |